BridgeBio Pharma, Inc.
BBIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $643 | $749 | $541 | $681 |
| Short-Term Investments | $3 | $8 | $0 | $0 |
| Receivables | $117 | $77 | $115 | $5 |
| Inventory | $25 | $18 | $4 | $0 |
| Other Curr. Assets | $52 | $60 | $35 | $35 |
| Total Curr. Assets | $839 | $912 | $695 | $721 |
| Property Plant & Equip (Net) | $12 | $12 | $14 | $13 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $29 | $30 | $28 | $24 |
| Long-Term Investments | $92 | $110 | $128 | $144 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $26 | $16 | $17 | $18 |
| Total NC Assets | $159 | $168 | $186 | $199 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $998 | $1,080 | $882 | $919 |
| Liabilities | – | – | – | – |
| Payables | $19 | $26 | $28 | $10 |
| Short-Term Debt | $5 | $14 | $5 | $5 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $9 | $11 | $0 | $0 |
| Other Curr. Liab. | $184 | $125 | $119 | $140 |
| Total Curr. Liab. | $217 | $176 | $152 | $154 |
| LT Debt | $1,854 | $2,668 | $1,853 | $1,726 |
| Deferred Rev, NC | $13 | $15 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $837 | $1 | $515 | $496 |
| Total NC Liab. | $2,704 | $2,683 | $2,368 | $2,223 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $9 | $9 | $10 | $9 |
| Total Liabilities | $2,921 | $2,859 | $2,520 | $2,377 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$3,628 | -$3,446 | -$3,264 | -$3,096 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $1,695 | $1,658 | $1,615 | $1,628 |
| Total Equity | -$1,933 | -$1,788 | -$1,648 | -$1,468 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $10 | $9 | $10 | $10 |
| Total Liab. & Tot. Equity | $998 | $1,080 | $882 | $919 |
| Net Debt | $1,217 | $1,933 | $1,318 | $1,049 |